Is It Possible to Preserve Vision without Compromising Metastases-Free Survival by Use of Fully Fractionated Stereotactic Radiotherapy for Posterior Choroidal Melanoma?
Claire E PhillipsArkan YoussefMathias BresselRod O'DayJoseph SiaJohn D McKenzieDaniel McKayWilliam CampbellFred Kuanfu ChenPublished in: Ocular oncology and pathology (2024)
Meaningful vision was preserved 5 years after SRT, despite high-risk tumour locations for vision loss. 2yFFLP and 5yMFS were acceptable. This dose fractionation warrants further investigation.